Steve G. Dance
Plus aucun poste en cours
Profil
Mr. Stephen G.
Dance has over thirty years of experience in finance and accounting, primarily in the pharmaceutical and biotechnology industries.
He served as Chief Financial Officer at NICHQ, a company focused on improving the quality of children's health care.
From 2004 to 2007, he served as Senior Vice President, Finance and Chief Financial Officer at ViaCell, Inc., a biotechnology company, including taking ViaCell public in 2005.
From 1999 until 2003, he was Senior Vice President, Finance and Chief Financial Officer at SangStat Medical Corporation, a publicly-held biotechnology company.
He spent fifteen years with Syntex Corporation, a pharmaceuticals company (later part of the Roche group), in a variety of increasingly responsible finance positions including controller of all US pharmaceutical operations.
Mr. Dance holds a BA degree in French and Spanish from the University of Leeds in England.
He is a Certified Public Accountant.
Anciens postes connus de Steve G. Dance
| Sociétés | Poste | Fin |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 29/06/2007 |
| SangStat Medical Corp. | Directeur Financier/CFO | 01/12/2003 |
| Syntex Corp. | Corporate Officer/Principal | - |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | - |
Formation de Steve G. Dance
| University of Leeds | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
| Syntex Corp. | Health Technology |